Ever Neuro Pharma

NCT07588932

Collaborator, Early phase 1, Recruiting, 2026, 50 people, 15 May 2026, clinicaltrials.gov

NCT07540338

Phase 1/2, Recruiting, 2026, 20 people, 20 Apr 2026, clinicaltrials.gov

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

Collaborator, Phase 2, Recruiting, 2026, 30 people, 10 Nov 2025, clinicaltrials.gov

NCT06921590

Phase 1, Completed, 2025, 15 people, 10 Apr 2025, clinicaltrials.gov

NCT02469896

Collaborator, Phase 2, Completed, 2015, 22 people, 12 Jun 2015, clinicaltrials.gov

NCT01975324

Phase 4, Completed, 2013, 20 people, 4 Nov 2013, clinicaltrials.gov

NCT01822951

Phase 4, Withdrawn, 0 people, 4 Apr 2013, clinicaltrials.gov

NCT01805453

Collaborator, Phase 3, Completed, 2013, 80 people, 6 Mar 2013, clinicaltrials.gov

NCT01734512

Collaborator, Phase 2, Completed, 2012, 65 people, 27 Nov 2012, clinicaltrials.gov

NCT00911807

Phase 2, Completed, 2004, 217 people, 2 Jun 2009, clinicaltrials.gov

NCT00822900

Collaborator, Phase 3, Terminated, 2010, 882 people, 15 Jan 2009, clinicaltrials.gov

The balance of local and distributed excitation shapes brain stability and reflects aging- and Alzheimer's disease-related alterations

24 Sept 2026, api.crossref.org